BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15278064)

  • 1. Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study.
    Falk GW; Skacel M; Gramlich TL; Casey G; Goldblum JR; Tubbs RR
    Gastrointest Endosc; 2004 Aug; 60(2):280-4. PubMed ID: 15278064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens.
    Fahmy M; Skacel M; Gramlich TL; Brainard JA; Rice TW; Goldblum JR; Connor JT; Casey G; Legator MS; Tubbs RR; Falk GW
    Mod Pathol; 2004 May; 17(5):588-96. PubMed ID: 15017433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
    Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
    Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus.
    Geisinger KR; Teot LA; Richter JE
    Cancer; 1992 Jan; 69(1):8-16. PubMed ID: 1727677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma.
    Rossi E; Villanacci V; Bassotti G; Donato F; Festa A; Cengia G; Grisanti S; Cestari R
    Histopathology; 2010 Jul; 57(1):81-9. PubMed ID: 20557373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus.
    Brankley SM; Wang KK; Harwood AR; Miller DV; Legator MS; Lutzke LS; Kipp BR; Morrison LE; Halling KC
    J Mol Diagn; 2006 May; 8(2):260-7. PubMed ID: 16645214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma.
    Brankley SM; Halling KC; Jenkins SM; Timmer MR; Iyer PG; Smyrk TC; Barr Fritcher EG; Voss JS; Kipp BR; Campion MB; Lutzke LS; Minot DM; Wang KK
    Dis Esophagus; 2016 Aug; 29(6):513-9. PubMed ID: 26043762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus.
    Poneros JM; Faye AS; Barr Fritcher EG; Sen A; Anandasabapathy S; Bresalier RS; Marcon N; Turgeon DK; Appelman H; Normolle D; Morrison LE; Brenner DE; Halling KC
    Dig Dis Sci; 2017 May; 62(5):1216-1222. PubMed ID: 28265829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus.
    Fritcher EG; Brankley SM; Kipp BR; Voss JS; Campion MB; Morrison LE; Legator MS; Lutzke LS; Wang KK; Sebo TJ; Halling KC
    Hum Pathol; 2008 Aug; 39(8):1128-35. PubMed ID: 18602665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of brush cytology in the diagnosis of Barrett's esophagus: an analysis of eight cases.
    Padmavathy F; Siddaraju N; Sistla SC
    Diagn Cytopathol; 2011 Jan; 39(1):60-4. PubMed ID: 21162095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphology of Barrett's esophagus and Barrett's-associated dysplasia and adenocarcinoma.
    Antonioli DA; Wang HH
    Gastroenterol Clin North Am; 1997 Sep; 26(3):495-506. PubMed ID: 9309400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytology in Barrett's esophagus.
    Falk GW
    Gastrointest Endosc Clin N Am; 2003 Apr; 13(2):335-48. PubMed ID: 12916664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.
    Walch AK; Zitzelsberger HF; Bruch J; Keller G; Angermeier D; Aubele MM; Mueller J; Stein H; Braselmann H; Siewert JR; Höfler H; Werner M
    Am J Pathol; 2000 Feb; 156(2):555-66. PubMed ID: 10666385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens.
    Rygiel AM; Milano F; Ten Kate FJ; de Groot JG; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Genes Chromosomes Cancer; 2008 May; 47(5):396-404. PubMed ID: 18265409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
    Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H
    Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
    Hao Y; Triadafilopoulos G; Sahbaie P; Young HS; Omary MB; Lowe AW
    Gastroenterology; 2006 Sep; 131(3):925-33. PubMed ID: 16952561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
    Morales CP; Lee EL; Shay JW
    Cancer; 1998 Aug; 83(4):652-9. PubMed ID: 9708927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts.
    Hoefnagel SJM; Mostafavi N; Timmer MR; Lau CT; Meijer SL; Wang KK; Krishnadath KK
    PLoS One; 2020; 15(4):e0231419. PubMed ID: 32282835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
    Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
    Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.